The real-world effectiveness of Monjuvi (tafasitamab-cxix) in U.S. patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) was confirmed, along with factors associated with survival ...

"This is one of the first large, real-world, long-term studies to assess the efficacy of hydroxyurea outside of a controlled setting," said study author Paul George, MD, a pediatric hematology ...

Patients Patients with newly diagnosed standard-risk B-cell ALL, with or without Down’s syndrome, who did not have testicular leukemia or frank central nervous system (CNS) disease were eligible.

Lung cancer is the most common malignancy and the leading cause of cancer-related deaths worldwide, and with approximately 2.2 million new cases and 1.8 million deaths in 2020, lung cancer remains a ...